Clinical Study on Xuesaitong Soft Capsule for Patients with Unstable Angina Pectoris: a Randomized Controlled Trial

Xiyuan Hospital of China Academy of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Aged 40-75 years, male or female;
•2. Patients who meet the diagnosis of unstable angina pectoris and undergo coronary intervention.

•Those who meet any of the following are excluded:
•1. Those with hypertension who still have high blood pressure after treatment with antihypertensive drugs (systolic blood pressure >= 180mmHg, diastolic blood pressure >= 100mmHg);
•2. Severe arrhythmia (atrial fibrillation with rapid ventricular response, atrial flutter, paroxysmal ventricular tachycardia, etc.);
•3. Pulmonary heart disease, rheumatic heart disease, myocarditis, cardiomyopathy, aortic dissection, pulmonary embolism;
•4. Gastrointestinal ulcer;
•5. History of infection, fever, trauma, burns, and surgery within the past month;
•6. Acute myocardial infarction or acute stroke in the past month;
•7. Active rheumatoid immune disease;
•8. Active tuberculosis;
•9. Those whose serum alanine aminotransferase or serum creatinine is > 2 times the upper limit of the normal reference value;
•10. People with severe hematological diseases;
•11. Malignant tumors;
•12. Pregnant women, lactating women, or women of childbearing age with childbearing requirements;
•13. People with mental illness or cognitive impairment;
•14. Those who are allergic to the test drug;
•15. Participants in other clinical trials in the last 1 month;
•16. Those who refuse to sign the informed consent.

发起方

Xiyuan Hospital of China Academy of Traditional Chinese Medicine